[引用][C] Improved survival among hospitalized patients with COVID-19 treated with remdesivir and dexamethasone. A nationwide population-based cohort study

T Benfield, J Bodilsen, C Brieghel… - Clinical Infectious …, 2021 - Oxford University Press

Effectiveness of remdesivir treatment protocols among patients hospitalized with COVID-19: a target trial emulation

A Breskin, C Wiener, AA Adimora, RS Brown Jr… - …, 2023 - journals.lww.com
Background: Remdesivir is recommended for certain hospitalized patients with COVID-19.
However, these recommendations are based on evidence from small randomized trials …

[PDF][PDF] Remdesivir mortality benefit in mechanically ventilated COVID-19 patients: a retrospective review

S Asselstine, K Ly, Z Khan, N Shah - J Infect Dis Epidemiol, 2020 - scholar.archive.org
Objective: COVID-19 has presented unprecedented challenges due to the sparse
availability of information surrounding the novel virus; continuing to gather data on the …

[HTML][HTML] Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital …

M Lucijanić, N Bušić, P Bistrović, I Papić… - Croatian medical …, 2022 - ncbi.nlm.nih.gov
Aim To evaluate the association of remdesivir use and the survival of hospitalized patients
with coronavirus disease 2019 (COVID-19). Methods We retrospectively reviewed the …

Remdesivir use and antimicrobial stewardship restrictions during the coronavirus disease 2019 (COVID-19) pandemic in the United States: A cross-sectional survey

AJM Lora, R Burgos, S Borgetti… - Antimicrobial …, 2023 - cambridge.org
Deploying therapeutics for coronavirus disease 2019 (COVID-19) has proved challenging
due to evolving evidence, supply shortages, and conflicting guideline recommendations. We …

Clinical improvement, outcomes, antiviral activity, and costs associated with early treatment with remdesivir for patients with coronavirus disease 2019 (COVID-19)

CKH Wong, KTK Lau, ICH Au, X Xiong… - Clinical Infectious …, 2022 - academic.oup.com
Background Evidence remains inconclusive on any significant benefits of remdesivir in
patients with mild-to-moderate COVID-19. This study explored the disease progression …

[HTML][HTML] Early use of remdesivir in patients hospitalized with COVID-19 improves clinical outcomes: a retrospective observational study

N Paranjape, M Husain, J Priestley… - Infectious Diseases in …, 2021 - journals.lww.com
Background Remdesivir treatment, like most antiviral drugs, is likely to be most effective
when used early in the course of coronavirus disease 2019 (COVID-19). Optimal timing of …

Remdesivir for adults with COVID-19: a living systematic review for American College of Physicians practice points

TJ Wilt, AS Kaka, R MacDonald, N Greer… - Annals of Internal …, 2021 - acpjournals.org
An updated version of this article was published on 1 March 2022. Background: Few
treatments exist for coronavirus disease 2019 (COVID-19). Purpose: To evaluate the …

Remdesivir use in patients requiring mechanical ventilation due to COVID-19

G Lapadula, DP Bernasconi, G Bellani… - Open forum …, 2020 - academic.oup.com
Background Remdesivir has been associated with accelerated recovery of severe
coronavirus disease 2019 (COVID-19). However, whether it is also beneficial in patients …

[HTML][HTML] Effect of remdesivir on mortality and the need for mechanical ventilation among hospitalized patients with COVID-19: real-world data from a resource-limited …

R Metchurtchlishvili, N Chkhartishvili, A Abutidze… - International Journal of …, 2023 - Elsevier
Objectives Georgia introduced remdesivir for the treatment of COVID-19 in December 2020.
We evaluated the real-world effect of remdesivir on mortality and the need for mechanical …